KMW III

Katie's Midnight Walk was quite well attended again, by a much younger crowd than in previous years....

Monoclonals

A new US MM patient asked me if I knew of any trials of an new agent I had not heard about previously, MDX-1106. It turns back on the immune cells which MM turns off. Only phase I trials available at present.

I also see that another monoclonal antibody, ipilimumab's phase II trial continues to look promising, but has some odd side-effects...

Updates

There have been a number of updates to the site, including moving "Steve's story" to the In-Memoriam section, as a result of information received.

I have sadly heard of a number of other melanomates who have passed away or moved to stage 4 in the recent past.

Melanoma's a serious business, alright.